These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38003943)

  • 21. Glycemic Improvement Using Continuous Glucose Monitoring by Baseline Time in Range: Subgroup Analyses from the DIAMOND Type 1 Diabetes Study.
    Calhoun P; Price D; Beck RW
    Diabetes Technol Ther; 2021 Mar; 23(3):230-233. PubMed ID: 33006904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters.
    Lameijer A; Lommerde N; Dunn TC; Fokkert MJ; Edens MA; Kao K; Xu Y; Gans ROB; Bilo HJG; van Dijk PR
    Diabetes Res Clin Pract; 2021 Jul; 177():108897. PubMed ID: 34098059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
    Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
    Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
    Al Hayek AA; Al Dawish MA
    Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time in range following flash glucose monitoring: Relationship with glycaemic control, diabetes-related distress and resource utilisation in the Association of British Clinical Diabetologists national audit.
    Deshmukh H; Wilmot E; Pieri B; Choudhary P; Shah N; Gregory R; Kilvert A; Lumb A; Christian P; Barnes D; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabet Med; 2022 Nov; 39(11):e14942. PubMed ID: 36054655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial.
    Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J
    Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
    Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
    Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucose-lowering effects of 7-day treatment with SGLT2 inhibitor confirmed by intermittently scanned continuous glucose monitoring in outpatients with type 1 diabetes. A pilot study.
    Kurozumi A; Okada Y; Tanaka Y
    Endocr J; 2021 Mar; 68(3):361-369. PubMed ID: 33208570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring.
    Díaz-Soto G; Bahíllo-Curieses MP; Jimenez R; Nieto MO; Gomez E; Torres B; López Gomez JJ; de Luis D
    Endocrinol Diabetes Nutr (Engl Ed); 2021; 68(7):465-471. PubMed ID: 34863411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The usefulness of the FlashStyle Libre system in glycemic control in children with type 1 diabetes during summer camp.
    Deja G; Kłeczek M; Chumięcki M; Strzała-Kłeczek A; Deja R; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2018; 24(1):11-19. PubMed ID: 30083658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of flash glucose monitoring and glucose metrics: real-world observational data from Saudi Arabia.
    Al-Harbi MY; Albunyan A; Alnahari A; Kao K; Brandner L; El Jammal M; Dunn TC
    Diabetol Metab Syndr; 2022 May; 14(1):66. PubMed ID: 35501880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of scan frequency with CGM-derived metrics and influential factors in adults with type 1 diabetes mellitus.
    Sakane N; Hirota Y; Yamamoto A; Miura J; Takaike H; Hoshina S; Toyoda M; Saito N; Hosoda K; Matsubara M; Tone A; Kawashima S; Sawaki H; Matsuda T; Domichi M; Suganuma A; Sakane S; Murata T
    Diabetol Int; 2024 Jan; 15(1):109-116. PubMed ID: 38264231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring-derived glycemic makers in children and adolescents with type 1 diabetes.
    Suzuki J; Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Morioka I
    Pediatr Int; 2021 Feb; 63(2):154-159. PubMed ID: 32744360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Association of Personality Traits and Parameters of Glycemic Regulation in Type 1 Diabetes Mellitus Patients Using isCGM.
    Sladić Rimac D; Bilić Ćurčić I; Prpić Križevac I; Schonberger E; Centner MG; Barišić M; Canecki Varžić S
    Healthcare (Basel); 2022 Sep; 10(9):. PubMed ID: 36141404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study
    Préau Y; Galie S; Schaepelynck P; Armand M; Raccah D
    Sensors (Basel); 2021 Sep; 21(18):. PubMed ID: 34577338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial.
    Boucher SE; Gray AR; Wiltshire EJ; de Bock MI; Galland BC; Tomlinson PA; Rayns JA; MacKenzie KE; Chan H; Rose S; Wheeler BJ
    Diabetes Care; 2020 Oct; 43(10):2388-2395. PubMed ID: 32788281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic Review of Randomized Controlled Trials Evaluating Glycemic Efficacy and Patient Satisfaction of Intermittent-Scanned Continuous Glucose Monitoring in Patients with Diabetes.
    Cowart K; Updike W; Bullers K
    Diabetes Technol Ther; 2020 May; 22(5):337-345. PubMed ID: 31859531
    [No Abstract]   [Full Text] [Related]  

  • 39. Intermittently Scanned Glucose Values for Continuous Monitoring: Cross-Sectional Analysis of Glycemic Control and Hypoglycemia in 1809 Children and Adolescents with Type 1 Diabetes.
    Biester T; Grimsmann JM; Heidtmann B; Rami-Merhar B; Ermer U; Wolf J; Freff M; Karges B; Agena D; Bramlage P; Danne T; Holl RW
    Diabetes Technol Ther; 2021 Mar; 23(3):160-167. PubMed ID: 33084351
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.